Key Clinical Formulas & Scores
20/20 = Normal vision (can read at 20 feet what a normal eye reads at 20 feet)
20/40 = Can read at 20 feet what a normal eye reads at 40 feet
20/200 = Legal blindness threshold (can read at 20 feet what a normal eye reads at 200 feet)
Testing distance: 20 feet (6 meters)
Denominator = distance at which the smallest letter read can be read by a person with normal vision
Normal IOP: 10-21 mmHg
Ocular hypertension: IOP >21 mmHg without optic nerve damage
Low-tension glaucoma: IOP โค21 mmHg with glaucomatous optic neuropathy
High-risk IOP: >25-30 mmHg (requires treatment)
Delta IOP: >3-4 mmHg between eyes is suspicious for glaucoma
Mild NPDR: Microaneurysms only
Moderate NPDR: Microaneurysms + hemorrhages, hard exudates, cotton wool spots
Severe NPDR: 4-2-1 rule (hemorrhages in 4 quadrants, venous beading in 2+, IRMA in 1+)
PDR: Neovascularization (NVD, NVE) or vitreous hemorrhage
Diabetic Macular Edema: center-involved (CI-DME) vs non-center-involved
Treatment: Anti-VEGF (ranibizumab, aflibercept, bevacizumab) for DME/PDR, focal/grid laser, vitrectomy for non-clearing vitreous hemorrhage
Primary Open-Angle: chronic, asymptomatic, elevated IOP, optic disc cupping (C/D >0.6), visual field defects
Angle-Closure: acute (IOP >40, mid-dilated pupil, corneal edema, shallow AC) vs chronic
Normal-Tension: glaucomatous damage despite IOP โค21 mmHg
Primary congenital: buphthalmos, corneal edema, Haab striae
Staging: Mild (C/D <0.7, MD >-6dB), Moderate (C/D 0.7-0.8, MD -6 to -12dB), Severe (C/D >0.8, MD <-12dB)
Normal CCT: ~540-550 ฮผm
Thin cornea (<520 ฮผm): underestimates true IOP
Thick cornea (>580 ฮผm): overestimates true IOP
Correction: For every 10 ฮผm deviation from 550, adjust IOP by ~0.3-0.5 mmHg
Pachymetry-guided: true IOP โ measured IOP + (550 - CCT)/50 ร 0.5
Ocular Response Analyzer: measures corneal hysteresis (CH) โ lower CH = higher glaucoma risk
Core Concepts
Cataract Classification & Surgery
Types: Nuclear sclerotic (most common, myopic shift), cortical (wedge-shaped opacities, glare), posterior subcapsular (central visual impairment, diabetes/steroid-related). Indications for surgery: visual acuity 20/50 or worse, symptomatic glare, inability to perform daily activities, phacolytic/uveitic complications. Procedure: phacoemulsification with foldable IOL implantation. IOL types: monofocal (standard), toric (astigmatism), multifocal/EDOF (presbyopia-correcting). Post-op: topical antibiotic + steroid, YAG capsulotomy if posterior capsule opacification.
Acute Angle-Closure Glaucoma (AACG)
Pathophysiology: pupil block โ iris bombe โ acute angle closure โ rapid IOP rise. Symptoms: severe eye pain, headache, nausea/vomidting, blurred vision, halos around lights. Signs: mid-dilated fixed pupil (6mm), corneal edema (steamy), shallow anterior chamber, IOP 50-80 mmHg. Emergency treatment: IV acetazolamide 500mg, topical beta-blocker (timolol), alpha-2 agonist (brimonidine), pilocarpine 2% (once IOP <40), IV mannitol 1-2 g/kg. Definitive: laser peripheral iridotomy (LPI) once cornea clears. Prophylactic LPI in fellow eye.
Retinal Detachment Classification
Rhegmatogenous (most common): retinal break (tear/hole) โ fluid accumulates โ separation. Symptoms: flashes (photopsia), floaters (myodesopsia), curtain-like visual field loss. Tractional: fibrovascular membranes pull retina (diabetic retinopathy, ROP). Exudative: fluid accumulation without break (inflammatory, tumor, vascular). Macula-on vs maca-off determines urgency. Treatment: macula-off = emergency. Pneumatic retinopexy, scleral buckle, pars plana vitrectomy (with gas/silicone oil tamponade). Positioning post-op critical for gas tamponade.
Clinical Case Studies
Case 1: Acute Angle-Closure Glaucoma
Patient: 68-year-old female, sudden left eye pain, headache, nausea, blurred vision with halos around lights for 4 hours. Exam: VA 20/200 OS, mid-dilated pupil 6mm non-reactive, cornea steamy/edematous, IOP 62 mmHg OS (15 mmHg OD), shallow anterior chamber.
Diagnosis: Acute angle-closure attack OS.
Management: Immediate: acetazolamide 500mg IV, timolol 0.5% topical, brimonidine 0.15% topical, pilocarpine 2% (after IOP <40), mannitol 20% 1.5 g/kg IV. Ophthalmology stat. Once IOP controlled and cornea clears: YAG laser peripheral iridotomy within 24 hours. Fellow eye: prophylactic LPI. Long-term: lens extraction (cataract surgery) may be definitive if contributing to pupillary block.
Case 2: Diabetic Macular Edema
Patient: 58-year-old male, type 2 diabetes ร 12 years, gradual central vision loss OD. HbA1c 8.9%. FA shows diffuse leakage and microaneurysms. OCT: central subfield thickness 420 ฮผm (normal <300 ฮผm), intraretinal cysts, no vitreomacular traction.
Diagnosis: Center-involved diabetic macular edema (CI-DME) OD.
Management: Anti-VEGF first-line: aflibercept 2mg intravitreal monthly ร 5 loading doses, then treat-and-extend protocol. Target: reduction in CST and improvement in VA. Adjunct: glycemic control (HbA1c <7%), blood pressure control, lipid management. If suboptimal response after 6 injections: switch anti-VEGF agent or add focal/grid laser photocoagulation. Regular monitoring: OCT monthly during loading phase.
Case 3: Retinal Artery Occlusion (CRAO)
Patient: 72-year-old male, sudden painless vision loss in right eye 3 hours ago. VA: CF at 1 foot OD, 20/25 OS. Pupil: APD positive OD. Fundus: retina pale/edematous, cherry-red spot at fovea, Hollenhorst plaque at bifurcation.
Diagnosis: Central retinal artery occlusion (CRAO).
Management: This is an ocular stroke โ time-critical! Immediate: ocular massage (repeated pressure ร 10 sec), IV acetazolamide 500mg to lower IOP, hyperventilation with carbogen (95% Oโ/5% COโ), IV fibrinolysis (tPA) within 4.5 hours (controversial, EAGLE trial). Anterior chamber paracentesis. Workup for stroke risk: carotid Doppler, echocardiogram, Holter monitor. Long-term: manage HTN, hyperlipidemia, diabetes, antiplatelet therapy. Prognosis: poor if >4 hours โ permanent vision loss likely.
Practice Questions
A: Corrected IOP โ 22 + (550-580)/50 ร 0.5 = 22 - 0.3 = ~21.7 mmHg. Thick cornea overestimates IOP by ~0.3 mmHg in this case. Actually thick cornea makes true IOP higher than measured, so true IOP = 22 + 0.3 = ~22.3 mmHg.
A: 4 = microaneurysms/hemorrhages in 4 quadrants, 2 = venous beading in 2+ quadrants, 1 = IRMA (intraretinal microvascular abnormalities) in 1+ quadrant. Any one criterion = severe NPDR.
A: Anti-VEGF intravitreal injections (aflibercept, ranibizumab, or bevacizumab). Aflibercept has the strongest evidence for DME (VIVID/VISTA trials).
A: Flashes of light (photopsia), sudden increase in floaters, and a curtain-like shadow or veil over the visual field. Macula-off = surgical emergency.
A: Laser peripheral iridotomy (LPI) โ creates an alternative aqueous flow pathway, relieving pupillary block. Prophylactic LPI in the fellow eye is also recommended.